151 - 175 of 7916 Results
Title
Year
- Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease2024OPENTitle: Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-65010-7Citation Count: 0
- Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's Disease2024OPENTitle: Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29892Citation Count: 0
-
RESTRICTEDTitle: Revised criteria for the diagnosis and staging of Alzheimer’s diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-024-02988-7Citation Count: 7
-
OPENTitle: The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1Journal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 26Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adk1296Citation Count: 1
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup2024OPENTitle: Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13859Best OA location URL: https://doi.org/10.1002/alz.13859Citation Count: 52
-
OPENTitle: Selective Activation of the Spinal Cord with Epidural Electrical StimulationJournal Name: Brain SciencesPublisher: MDPI AGVol: 14Issue #: 7Start Page: 650End Page: 650Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci14070650Citation Count: 0
-
OPENTitle: Assessment tools for cognitive performance in Parkinson’s disease and its genetic contributorsJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2024.1413187Citation Count: 0
-
OPENTitle: Divergent landscapes of A-to-I editing in postmortem and living human brainJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49268-zBest OA location URL: https://doi.org/10.1038/s41467-024-49268-zCitation Count: 0
-
OPENTitle: Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBADJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 31Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41594-024-01338-yBest OA location URL: https://www.nature.com/articles/s41594-024-01338-y.pdfCitation Count: 3
- Prediction of motor and non-motor Parkinson’s disease symptoms using serum lipidomics and machine learning: a 2-year study2024OPENTitle: Prediction of motor and non-motor Parkinson’s disease symptoms using serum lipidomics and machine learning: a 2-year studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00741-yCitation Count: 0
- Synchronous Measurements of Extracellular Action Potentials and Neurochemical Activity with Carbon Fiber Electrodes in Nonhuman Primates2024OPENTitle: Synchronous Measurements of Extracellular Action Potentials and Neurochemical Activity with Carbon Fiber Electrodes in Nonhuman PrimatesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 11Issue #: 7Start Page: ENEURO.0001End Page: 24.2024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-sa, cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0001-24.2024Citation Count: 0
- The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease2024OPENTitle: The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-65640-xCitation Count: 0
- An interpretable machine learning‐based cerebrospinal fluid proteomics clock for predicting age reveals novel insights into brain aging2024OPENTitle: An interpretable machine learning‐based cerebrospinal fluid proteomics clock for predicting age reveals novel insights into brain agingJournal Name: Aging CellPublisher: WileyVol: 23Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.14230Citation Count: 0
- Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease2024OPENTitle: Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14145Citation Count: 0
- Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol2024OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Citation Count: 0
-
OPENTitle: Open-source platform for kinematic analysis of mouse forelimb movementJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 5Issue #: 3Start Page: 103140End Page: 103140Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.xpro.2024.103140Citation Count: 0
- Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial2024OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Citation Count: 3
- Very low levels of ABCA7 in the cerebrum and Alzheimer’s disease onset between the ages of 60 and 80 independently of APOE2024RESTRICTEDTitle: Very low levels of ABCA7 in the cerebrum and Alzheimer’s disease onset between the ages of 60 and 80 independently of APOEJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 83Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlae060Citation Count: 0
- The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons2024OPENTitle: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neuronsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49256-3Citation Count: 0
- Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset2024OPENTitle: Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onsetJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-48961-3Best OA location URL: https://www.nature.com/articles/s41467-024-48961-3.pdfCitation Count: 5
- Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease2024OPENTitle: Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson diseaseJournal Name: Nature Mental HealthPublisher: Springer Science and Business Media LLCVol: 2Issue #: 8Start Page: 916End Page: 923Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s44220-024-00256-8Citation Count: 0
- Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates2024OPENTitle: Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primatesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00735-wBest OA location URL: https://www.nature.com/articles/s41531-024-00735-w.pdfCitation Count: 0
- Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology2024OPENTitle: Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathologyJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49402-xBest OA location URL: https://doi.org/10.1038/s41467-024-49402-xCitation Count: 5
-
OPENTitle: Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathiesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49258-1Citation Count: 0
- Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimetic2024OPENTitle: Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimeticJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 6Start Page: e0304603End Page: e0304603Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0304603Citation Count: 0